Health · 2 views
FDA Expands Ryzumvi Approval to Include Presbyopia
(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics…
Summary
(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics and Viatris
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Protein discovery reveals potential treatment target for common fatty liver diseaseContinue reading
- Percival AI can uncover unseen health issues in CT scansContinue reading
- Proposed changes to hepatitis B vaccination schedule could significantly increase infections, model suggestsContinue reading
- Are your bones brittle? If they were, how would you know? (To men: this goes for you too) | Ranjana SrivastavaContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow